You are looking at 1 - 4 of 4 items for
- Author or Editor: Katrina Viviano x
- Refine by Access: All Content x
OBJECTIVE To evaluate the clinical performance of a commercially available compartmentalized urine culture and antimicrobial susceptibility test plate (CCSP) for identification of canine bacteriuria and assessment of isolate antimicrobial susceptibility.
DESIGN Cross-sectional study.
ANIMALS 71 dogs.
PROCEDURES Urine samples (n = 84) were divided into 3 aliquots. One aliquot (reference culture) was plated on culture medium ≤ 1 hour after collection for quantitative culture and testing by standard laboratory methods, another was stored at 4°C for 24 hours (to mimic storage practices at primary care facilities) and then processed by standard methods, and the third was applied to a CCSP ≤ 1 hour after collection to be processed and interpreted according to manufacturer instructions. Results were compared with those for reference culture, which was used as the criterion reference standard. Sensitivity, specificity, positive and negative predictive values, and agreement between methods was evaluated.
RESULTS 43 isolates (25 single and 9 multiple isolates) were identified in 34 reference cultures. All results for stored cultures were identical to those for reference cultures. Overall sensitivity of the CCSP method to detect bacteriuria was 93%, and specificity was 100%. Thirty-three of 43 (77%) and 19 of 33 (58%) CCSP bacterial isolates were correctly identified to the genus and species level, respectively. The CCSP antimicrobial susceptibility results matched those for reference cultures for 13 of 33 (39%) isolates evaluated.
CONCLUSIONS AND CLINICAL RELEVANCE Limitations of the CCSP method included inaccuracy of some antimicrobial susceptibility test results and failure to correctly identify bacteriuria in some dogs.
Objective—To determine the prevalence of subclinical bacteriuria and its natural clinical course over a 3-month period in healthy female dogs.
Design—Observational, prospective, cross-sectional study.
Animals—101 healthy client-owned female dogs.
Procedures—In all dogs, screening clinicopathologic tests and bacteriologic culture of urine were performed. In culture-positive dogs, subclinical bacteriuria was confirmed by 2 positive culture results within 2 weeks and dogs were reevaluated at 3 months.
Results—The prevalence of subclinical bacteriuria in healthy female dogs was 9 of 101 (8.9%). Three-month follow-up data were available for 8 of 9 dogs with subclinical bacteriuria. Four dogs had persistent bacteriuria, and 4 had transient bacteriuria. No dogs with subclinical bacteriuria developed clinical signs during the 3-month observation period. Subclinical bacteriuria was diagnosed in 6 of 51 (12%) young and middle-aged dogs and 3 of 50 (6.0%) senior and geriatric dogs. No significant difference was found in the prevalence of subclinical bacteriuria with age.
Conclusions and Clinical Relevance—Results suggested that subclinical bacteriuria is a nonprogressive condition in healthy female dogs and can be persistent or transient. No significant difference in the prevalence of subclinical bacteriuria in young and middle-aged dogs versus senior and geriatric dogs was detected. No dogs with subclinical bacteriuria developed clinical signs requiring antimicrobial treatment during the 3-month observation period. Healthy female dogs with subclinical bacteriuria may be a population of dogs in which antimicrobial treatment is unnecessary.
To describe the prevalence of postoperative bacteriuria, clinical course of subclinical bacteriuria in the absence of antimicrobial intervention, clinical signs of bacteriuria that trigger antimicrobial treatment, and outcomes for dogs with subclinical bacteriuria following surgical decompression of acute intervertebral disc herniation (IVDH) Hansen type I.
Twenty client-owned dogs undergoing hemilaminectomy for acute (≤ 6 days) IVDH Hansen type I affecting the thoracolumbar spinal cord segments between August 2018 and January 2019.
In this prospective study, dogs were serially evaluated at presentation, hospital discharge, 2 weeks postoperatively, and between 4 and 6 weeks postoperatively. Dogs were monitored for clinical signs of bacteriuria, underwent laboratory monitoring (CBC, biochemical analyses, urinalysis, urine bacterial culture), and were scored for neurologic and urinary status. In the absence of clinical signs, bacteriuria was not treated with antimicrobials.
Four of the 18 dogs developed bacteriuria without clinical signs 4 days to 4 to 6 weeks after surgery. In all 4 dogs, bacteriuria resulted in lower urinary tract signs 13 to 26 weeks postoperatively. No dogs had evidence of systemic illness despite delaying antimicrobial treatment until clinical signs developed. New-onset incontinence was the only clinical sign in 3 dogs. All bacterial isolates had wide antimicrobial susceptibility. Bacteriuria and clinical signs resolved with beta-lactam antimicrobial treatment.
Postoperative bacteriuria occurs in some dogs with IVDH Hansen type I and, when present, may lead to clinical signs over time. Clinical signs of bacteriuria may be limited to new-onset urinary incontinence, inappropriate urination, or both. Delaying antimicrobial treatment until clinical signs of bacteriuria developed did not result in adverse consequences or systemic illness.